Targeting M2-like tumor-associated macrophages by using melittin-based pro-apoptotic peptide

The present invention relates to a melittin-anticancer drug conjugate in which melittin and an anticancer drug are conjugated, and to a method for preparing a melittin-anticancer drug conjugate by connecting melittin and an anticancer drug. A conjugate of the present invention is an anticancer mater...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JEONG, Jin-Hyun, KIM, Jeong-Dong, LEE, Chan-Ju, LEE, Do-Ha, BAE, Hyunsu
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a melittin-anticancer drug conjugate in which melittin and an anticancer drug are conjugated, and to a method for preparing a melittin-anticancer drug conjugate by connecting melittin and an anticancer drug. A conjugate of the present invention is an anticancer material for targeting M2-type tumor-associated TAMs and exhibits an excellent effect of selectively selecting M2-type tumor-associated TAMs, and thus can be used for a use of drug delivery for targeting M2-type tumor-associated macrophages.